CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 185 filers reported holding CYTOKINETICS INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,340 | +1.2% | 45,486 | +12.1% | 0.00% | 0.0% |
| Q2 2023 | $1,324 | -38.2% | 40,585 | -33.4% | 0.00% | -33.3% |
| Q1 2023 | $2,144 | -41.9% | 60,936 | -24.4% | 0.00% | -40.0% |
| Q4 2022 | $3,691 | -99.9% | 80,557 | -29.3% | 0.01% | -37.5% |
| Q3 2022 | $5,522,000 | -4.6% | 113,970 | -22.6% | 0.01% | 0.0% |
| Q2 2022 | $5,788,000 | -13.5% | 147,316 | -19.0% | 0.01% | +14.3% |
| Q1 2022 | $6,695,000 | +78.3% | 181,893 | +120.9% | 0.01% | +75.0% |
| Q4 2021 | $3,754,000 | +87.1% | 82,359 | +46.7% | 0.00% | +100.0% |
| Q3 2021 | $2,006,000 | +66.9% | 56,122 | -7.6% | 0.00% | +100.0% |
| Q2 2021 | $1,202,000 | -14.1% | 60,745 | +0.9% | 0.00% | -50.0% |
| Q1 2021 | $1,400,000 | +11.9% | 60,200 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $1,251,000 | +11.1% | 60,200 | +15.8% | 0.00% | 0.0% |
| Q3 2020 | $1,126,000 | -8.2% | 52,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $1,226,000 | +100.0% | 52,000 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $613,000 | +31.8% | 52,000 | +18.7% | 0.00% | 0.0% |
| Q4 2019 | $465,000 | -27.1% | 43,800 | -21.9% | 0.00% | 0.0% |
| Q3 2019 | $638,000 | +1.1% | 56,100 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $631,000 | +75.8% | 56,100 | +26.4% | 0.00% | – |
| Q1 2019 | $359,000 | +27.8% | 44,400 | 0.0% | 0.00% | – |
| Q4 2018 | $281,000 | -35.7% | 44,400 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $437,000 | +18.4% | 44,400 | 0.0% | 0.00% | – |
| Q2 2018 | $369,000 | -2.4% | 44,400 | -15.4% | 0.00% | – |
| Q1 2018 | $378,000 | -11.7% | 52,490 | 0.0% | 0.00% | -100.0% |
| Q4 2017 | $428,000 | -43.8% | 52,490 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $761,000 | +19.8% | 52,490 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $635,000 | +24.3% | 52,490 | +31.9% | 0.00% | 0.0% |
| Q1 2017 | $511,000 | +32.7% | 39,791 | +25.5% | 0.00% | 0.0% |
| Q4 2016 | $385,000 | +32.3% | 31,700 | 0.0% | 0.00% | – |
| Q3 2016 | $291,000 | -21.6% | 31,700 | -18.9% | 0.00% | -100.0% |
| Q2 2016 | $371,000 | -9.7% | 39,069 | -32.9% | 0.00% | 0.0% |
| Q1 2016 | $411,000 | -32.5% | 58,233 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $609,000 | +34.4% | 58,233 | -13.9% | 0.00% | 0.0% |
| Q3 2015 | $453,000 | +4.6% | 67,642 | +4.9% | 0.00% | 0.0% |
| Q2 2015 | $433,000 | +129.1% | 64,477 | +131.7% | 0.00% | – |
| Q1 2015 | $189,000 | -94.4% | 27,829 | -92.2% | 0.00% | -100.0% |
| Q1 2014 | $3,400,000 | – | 357,845 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |